NL300101I1 - Topisch ofthalmische formuleringen die olopatadinebevatten voor het behandelen van allergische oogz iekten. - Google Patents

Topisch ofthalmische formuleringen die olopatadinebevatten voor het behandelen van allergische oogz iekten.

Info

Publication number
NL300101I1
NL300101I1 NL300101C NL300101C NL300101I1 NL 300101 I1 NL300101 I1 NL 300101I1 NL 300101 C NL300101 C NL 300101C NL 300101 C NL300101 C NL 300101C NL 300101 I1 NL300101 I1 NL 300101I1
Authority
NL
Netherlands
Prior art keywords
eye diseases
topically
treatment
ophthalmic formulations
formulations containing
Prior art date
Application number
NL300101C
Other languages
English (en)
Other versions
NL300101I2 (nl
Original Assignee
Alcon Lab Inc
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23864859&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL300101(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alcon Lab Inc, Kyowa Hakko Kogyo Kk filed Critical Alcon Lab Inc
Publication of NL300101I1 publication Critical patent/NL300101I1/nl
Publication of NL300101I2 publication Critical patent/NL300101I2/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
NL300101C 1995-06-06 2002-09-19 Topisch ofthalmische formuleringen die olopatadinebevatten voor het NL300101I2 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/469,729 US5641805A (en) 1995-06-06 1995-06-06 Topical ophthalmic formulations for treating allergic eye diseases
PCT/US1996/006289 WO1996039147A2 (en) 1995-06-06 1996-05-03 Topical ophthalmic formulations containing doxepin derivatives for treating allergic eye diseases

Publications (2)

Publication Number Publication Date
NL300101I1 true NL300101I1 (nl) 2002-12-02
NL300101I2 NL300101I2 (nl) 2003-01-06

Family

ID=23864859

Family Applications (1)

Application Number Title Priority Date Filing Date
NL300101C NL300101I2 (nl) 1995-06-06 2002-09-19 Topisch ofthalmische formuleringen die olopatadinebevatten voor het

Country Status (20)

Country Link
US (1) US5641805A (nl)
EP (1) EP0799044B1 (nl)
JP (1) JP3068858B2 (nl)
KR (1) KR100202155B1 (nl)
CN (1) CN1082367C (nl)
AT (1) ATE220906T1 (nl)
AU (1) AU698854B2 (nl)
CA (1) CA2195094C (nl)
DE (2) DE69622527T2 (nl)
DK (1) DK0799044T3 (nl)
ES (1) ES2179198T3 (nl)
FI (1) FI970489A0 (nl)
LU (1) LU90969I2 (nl)
MX (1) MX9701013A (nl)
MY (1) MY116651A (nl)
NL (1) NL300101I2 (nl)
NO (1) NO311637B1 (nl)
PT (1) PT799044E (nl)
TW (1) TW438588B (nl)
WO (1) WO1996039147A2 (nl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859000A (en) * 1995-06-07 1999-01-12 University Of Utah Research Foundation Method for reducing mast cell mediated allergic reactions
KR100598723B1 (ko) * 1998-07-14 2006-07-11 알콘 매뉴팩츄어링, 리미티드 비알레르기성 안염증 질환 치료 및 안혈관신생 예방용약제를 제조하기 위한11-(3-디메틸아미노프로필리덴)-6,11-디하이드로디벤즈[β,ε]옥세핀-2-아세트산의 용도
US6174914B1 (en) 1999-06-15 2001-01-16 Alcon Laboratories, Inc. Method of inhibiting cytokine release from human ocular cells
CA2374002A1 (en) 1999-06-18 2000-12-28 Alcon Laboratories, Inc. Topical ophthalmic mast cell stabilizers for treating allergic eye diseases
ATE291913T1 (de) 2000-01-25 2005-04-15 Alcon Inc Antiallergische ophthalmische zubereitungen, geeignet zur anwendung mit kontaktlinsen
CN1173697C (zh) 2000-05-19 2004-11-03 爱尔康公司 用于治疗过敏性疾病的苯胺二硫化物衍生物
CN1172666C (zh) 2000-05-19 2004-10-27 爱尔康公司 用于治疗过敏性疾病的含有苯甲酰胺二硫化物衍生物的组合物
AU5567501A (en) 2000-05-19 2001-12-03 Alcon Universal Ltd Disulfide derivatives useful for treating allergic diseases
AU2002316887A1 (en) * 2001-05-03 2002-11-18 Novartis Ag Anti-ige antibody to treat ocular allergies
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
US7977376B2 (en) 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
BR0214643A (pt) * 2001-12-05 2004-11-03 Alcon Inc Aplicação de um antagonista h1, e um esteróide seguro para tratar rinite
US20050209312A1 (en) * 2004-03-19 2005-09-22 Bausch & Lomb Incorporated Carboxylic acid derivatives of doxepin formulations preserved with low-irritation preservative
US20050288283A1 (en) * 2004-06-28 2005-12-29 Alcon, Inc. Topical formulations for treating allergic diseases
CN103860540A (zh) * 2004-11-24 2014-06-18 爱尔康公司 奥洛他定在治疗鼻子过敏或发炎状态的制剂制备中的用途
ES2437077T3 (es) * 2005-07-08 2014-01-08 Senju Pharmaceutical Co., Ltd. Preparado oftálmico de absorción percutánea que comprende olopatadina
DK3150209T3 (da) 2006-03-31 2019-10-28 Vistakon Pharmaceuticals Llc Okulære allergibehandlinger
US20080139531A1 (en) * 2006-12-04 2008-06-12 Alcon Manufacturing Ltd. Use of connective tissue mast cell stabilizers to facilitate ocular surface re-epithelization and wound repair
ES2781090T3 (es) 2007-02-07 2020-08-28 Novartis Ag Formulaciones de olopatadina para administración nasal tópica
US20090182035A1 (en) * 2007-04-11 2009-07-16 Alcon Research, Ltd. Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
JP2010523695A (ja) * 2007-04-11 2010-07-15 アルコン リサーチ， リミテッド アレルギー性鼻炎およびアレルギー性結膜炎を処置するためのＴＮＦαのインヒビターおよび抗ヒスタミン薬の使用
US20100227917A1 (en) * 2007-09-06 2010-09-09 Masashi Nakakura EYE DROP CONTAINING DIBENZ[b,e]OXEPIN DERIVATIVE
US10517839B2 (en) * 2008-06-09 2019-12-31 Cornell University Mast cell inhibition in diseases of the retina and vitreous
IT1397503B1 (it) 2009-04-21 2013-01-16 F S I Fabbrica Italiana Sint Processo per la preparazione di olopatadina
MX2012000539A (es) * 2009-07-17 2012-02-28 Alcon Res Ltd Regimen de rocio nasal de olopatadina para niños.
WO2011027322A1 (en) 2009-09-03 2011-03-10 Ranbaxy Laboratories Limited Extended release dosage form containing olopatadine for oral administration
MX2012003693A (es) * 2009-10-01 2012-04-19 Alcon Res Ltd Composiciones de olopatadine y usos de las mismas.
TW201206936A (en) 2010-07-19 2012-02-16 Alcon Res Ltd Methods and compositions for the treatment of allergy
TWI544922B (zh) 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
CN103202833A (zh) * 2012-12-25 2013-07-17 常州市亚邦医药研究所有限公司 一种奥洛他定或其盐的药用组合物及其制备方法
US20150119455A1 (en) * 2013-10-31 2015-04-30 Nephron Pharmaceuticals Corporation Formulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370324A (en) * 1980-09-17 1983-01-25 Bernstein Joel E Method and composition for treating and preventing irritation of the eyes
US4923892A (en) * 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
GB8520662D0 (en) * 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
JPS6310784A (ja) * 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤

Also Published As

Publication number Publication date
DE10299034I2 (de) 2005-07-07
MX9701013A (es) 1997-05-31
KR100202155B1 (ko) 1999-06-15
DE69622527D1 (de) 2002-08-29
KR970704452A (ko) 1997-09-06
CA2195094A1 (en) 1996-12-12
JP3068858B2 (ja) 2000-07-24
DE69622527T2 (de) 2002-12-05
MY116651A (en) 2004-03-31
DE10299034I1 (de) 2003-01-23
WO1996039147A3 (en) 1997-02-20
DK0799044T3 (da) 2002-10-14
FI970489A (fi) 1997-02-05
NO970517L (no) 1997-04-03
AU698854B2 (en) 1998-11-12
US5641805A (en) 1997-06-24
WO1996039147A2 (en) 1996-12-12
JPH09510235A (ja) 1997-10-14
NL300101I2 (nl) 2003-01-06
AU5726196A (en) 1996-12-24
CA2195094C (en) 2002-02-26
LU90969I2 (fr) 2002-12-02
TW438588B (en) 2001-06-07
NO970517D0 (no) 1997-02-05
FI970489A0 (fi) 1997-02-05
NO311637B1 (no) 2001-12-27
ES2179198T3 (es) 2003-01-16
CN1161000A (zh) 1997-10-01
PT799044E (pt) 2002-11-29
EP0799044A2 (en) 1997-10-08
EP0799044B1 (en) 2002-07-24
ATE220906T1 (de) 2002-08-15
CN1082367C (zh) 2002-04-10

Similar Documents

Publication Publication Date Title
NL300101I1 (nl) Topisch ofthalmische formuleringen die olopatadinebevatten voor het behandelen van allergische oogz iekten.
PT1311285E (pt) Composicao farmaceutica liquida contendo um derivado de eritropoietina
CA2216796A1 (en) Quinazoline derivatives
NO995006L (no) Nye forbindelser
CA2321560A1 (en) The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy or ocular inflammation
CA2190303A1 (en) Pharmaceutical composition, method and device for preventing or treating dry eye or disease caused therefrom
DE69834500D1 (de) Xanthinderivative zur behandlung von hirnischämie
EP0842663A4 (en) OPHTHALMIC PREPARATIONS
IT1276031B1 (it) Composizione farmaceutica per il trattamento delle malattie autoimmuni
CA2320627A1 (en) Medicament for treatment of diastolic dysfunction
AU7587396A (en) Ocular depressor
EP0872239A3 (en) Use of olanzapine for the manufacture of a medicament for the treatment of cerebral focal ischemia
WO1998038985A3 (en) Use of carvedilol for the manufacture of a medicament for preventive and therapeutic treatment of inflammatory diseases
BR0209578A (pt) Uso de um gatran ou de um derivado farmaceuticamente aceitável do mesmo, método de tratamento de fibrose pulmonar, e, formulação farmacêutica